4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-19-008782
CEO, Pres, CFO, Treas & Secy bought 25,000 shares at $0.90 ($22,380)
From the SEC's structured data for this filing
Trades in this filing
KENYON LAWRENCE A · CEO, Pres, CFO, Treas & Secy
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-07 | Purchase : show line 1 in the form | +25,000 | $0.90 | $22,380 | 82,213 | D |
| Open-market purchases · 25,000 sh · avg $0.90 · $22,380 | ||||||
Loading xslF345X03/doc4.xml…